Physician

Barton Blackorby, MD

According to 2025 Medicare claims, Barton Blackorby, MD (NPI: 1477825875) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LLC (NPI: 1700175395; TIN: 430913832) and primary practice location at 62401-2190. Blackorby is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Blackorby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 768 traditional Medicare patients, billed 28,293 HCPCS/CPT codes, and received $1,416,285 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 574 prescription claims across 188 beneficiaries totaling $15,921 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 37 records totaling $5,905. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,754 to $1,416,285. In contrast, Part D prescription costs have fallen sharply in recent years, from $3,629 to $15,921. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$708K$1.4M2018 Medicare payment: $9,754 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $24,251 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $8,724 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $462,675 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,122,476 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,416,285 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20187084$9,754
2019165187$24,251
20206577$8,724
2021N/RN/RN/R
20222693,448$462,675
202358518,049$1,122,476
202476828,293$1,416,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.0K$16K2018 Drug cost: $3,629 (USD; Tot_Drug_Cst)2019 Drug cost: $8,556 (USD; Tot_Drug_Cst)2020 Drug cost: $9,123 (USD; Tot_Drug_Cst)2022 Drug cost: $3,149 (USD; Tot_Drug_Cst)2023 Drug cost: $2,818 (USD; Tot_Drug_Cst)2024 Drug cost: $15,921 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20186391$3,629
2019173258$8,556
202065110$9,123
2021N/RN/RN/R
20221323$3,149
20234271$2,818
2024188574$15,921

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more246306$103
67028Injection of drug into eye358800$92
92134Imaging of retina7191,469$31
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's256306$14
92202Extended exam of the back part of the eye with optic nerve drawing383519$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2136,976$7,704
Ketorolac TromethamineKetorolac Tromethamine1043,549$2,212
Brimonidine TartrateBrimonidine Tartrate633,149$1,738
MoxifloxacinMoxifloxacin Hcl38612$892
OfloxacinOfloxacin511,244$564

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.37$5,905Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Barton Blackorby, MD?

Tedicare shows public-source Medicare data for Barton Blackorby, MD (NPI 1477825875), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Barton Blackorby, MD have ACO affiliation data?

Barton Blackorby, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Barton Blackorby, MD?

Barton Blackorby, MD is linked to RETINA CONSULTANTS, LLC (billing NPI 1700175395) in the available physician profile data.

Does Barton Blackorby, MD have Open Payments data?

Barton Blackorby, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.